Skip to main content Accessibility help
×
Home
Hostname: page-component-55b6f6c457-5kt27 Total loading time: 0.224 Render date: 2021-09-25T03:00:53.542Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?

Published online by Cambridge University Press:  15 April 2020

J. Lyne*
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland
L. Renwick
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland
K. Madigan
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland
B. O’Donoghue
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland
M. Bonar
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland
T. Grant
Affiliation:
Centre for Support and Training in Analysis and Research (CSTAR), University College Dublin, Belfield, Dublin 4, Ireland
A. Kinsella
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland
K. Malone
Affiliation:
Department of Psychiatry, Psychotherapy and Mental Health Research, St. Vincent's University Hospital / School of Medicine and Medical Science, University College Dublin, Elm Park, Dublin 4, Ireland
N. Turner
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland
E. O’Callaghan
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland St. John of God Community Services Ltd., Blackrock, Co., Dublin, Ireland
M. Clarke
Affiliation:
Dublin and East Treatment and Early Care Team (DETECT) Services, Blackrock Co., Dublin, Ireland School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland St. John of God Community Services Ltd., Blackrock, Co., Dublin, Ireland
*
*Corresponding author. DETECT Services, Avila House, Block 5, Blackrock Business Park, Blackrock Co., Dublin, Ireland. Tel.: +353 1 2791700; fax: +353 1 2791799. E-mail address: johnlyne@mail.com (J. Lyne).
Get access

Abstract

Background:

Negative symptoms have been previously reported during the psychosis prodrome, however our understanding of their relationship with treatment-phase negative symptoms remains unclear.

Objectives:

We report the prevalence of psychosis prodrome onset negative symptoms (PONS) and ascertain whether these predict negative symptoms at first presentation for treatment.

Methods:

Presence of expressivity or experiential negative symptom domains was established at first presentation for treatment using the Scale for Assessment of Negative Symptoms (SANS) in 373 individuals with a first episode psychosis. PONS were established using the Beiser Scale. The relationship between PONS and negative symptoms at first presentation was ascertained and regression analyses determined the relationship independent of confounding.

Results:

PONS prevalence was 50.3% in the schizophrenia spectrum group (n = 155) and 31.2% in the non-schizophrenia spectrum group (n = 218). In the schizophrenia spectrum group, PONS had a significant unadjusted (χ2 = 10.41, P < 0.001) and adjusted (OR = 2.40, 95% CI = 1.11–5.22, P = 0.027) association with first presentation experiential symptoms, however this relationship was not evident in the non-schizophrenia spectrum group. PONS did not predict expressivity symptoms in either diagnostic group.

Conclusion:

PONS are common in schizophrenia spectrum diagnoses, and predict experiential symptoms at first presentation. Further prospective research is needed to examine whether negative symptoms commence during the psychosis prodrome.

Type
Original article
Copyright
Copyright © European Psychiatric Association 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Deceased author.

References

Addington, D, Addington, J, Maticka-Tyndale, EAssessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 1993 3944.CrossRefGoogle ScholarPubMed
an der Heiden, W, Hafner, HThe epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2000;250:292303.CrossRefGoogle ScholarPubMed
Andreasen, NCThe Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: University of Iowa; 1984.Google Scholar
Andreasen, NCThe Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: University of Iowa; 1984.Google Scholar
Andreasen, NC, Carpenter, W.T. Jr.Kane, JM, Lasser, RA, Marder, SR, Weinberger, DRRemission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441449.CrossRefGoogle ScholarPubMed
Beiser, M, Erickson, D, Fleming, JA, Iacono, WGEstablishing the onset of psychotic illness. Am J Psychiatry 1993;150:13491354.Google ScholarPubMed
Blanchard, JJ, Cohen, ASThe structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2006;32:238245.CrossRefGoogle ScholarPubMed
Blanchard, JJ, Kring, AM, Horan, WP, Gur, RToward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull 2011;37:291299.CrossRefGoogle Scholar
Bleuler, EDementia Praecox of the Group of Schizophrenias. New York, NY: International Universities Press; 1950.Google Scholar
Cannon, TD, Cadenhead, K, Cornblatt, B, Woods, SW, Addington, J, Walker, Eet al.Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:2837.CrossRefGoogle ScholarPubMed
Cannon-Spoor, HE, Potkin, SG, Wyatt, RJMeasurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470484.CrossRefGoogle ScholarPubMed
Crumlish, N, Whitty, P, Clarke, M, Browne, S, Kamali, M, Gervin, Met al.Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br J Psychiatry 2009;194:1824.CrossRefGoogle ScholarPubMed
Demjaha, A, Valmaggia, L, Stahl, D, Byrne, M, McGuire, PDisorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 2012;38:351359.CrossRefGoogle ScholarPubMed
Edwards, J, McGorry, PD, Waddell, FM, Harrigan, SMEnduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr Res 1999;40:147158.CrossRefGoogle ScholarPubMed
Fenton, WS, McGlashan, THNatural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry 1991;48:978986.CrossRefGoogle ScholarPubMed
First, MB, Spitzer, RL, Gibbon, M, Williams, JBStructured Clinical Interview for DSM-IV Axis I Disorders. New York: State Psychiatric Institute; 1995.Google Scholar
Herbener, ES, Harrow, MAre negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. Schizophr Bull 2004;30:813825.CrossRefGoogle ScholarPubMed
Iyer, SN, Boekestyn, L, Cassidy, CM, King, S, Joober, R, Malla, AKSigns and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories. Psychol Med 2008;38:11471156.CrossRefGoogle ScholarPubMed
Johnstone, EC, Ebmeier, KP, Miller, P, Owens, DG, Lawrie, SMPredicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005;186:1825.CrossRefGoogle ScholarPubMed
Klaassen, RM, Velthorst, E, Nieman, DH, de Haan, L, Becker, HE, Dingemans, PMet al.Factor analysis of the scale of prodromal symptoms: differentiating between negative and depression symptoms. Psychopathology 2011;44:379385.CrossRefGoogle ScholarPubMed
Kraepelin, EDementia praecox and paraphrenia. Edinburgh, Scotland: E and S Livingstone; 1919.Google Scholar
Lavoie, S, Schafer, MR, Whitford, TJ, Benninger, F, Feucht, M, Klier, CMFrontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis. Schizophr Res 2012;138:206211.CrossRefGoogle ScholarPubMed
Lencz, T, Smith, CW, Auther, A, Correll, CU, Cornblatt, BNonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004;68:3748.CrossRefGoogle ScholarPubMed
Lyne, J, O‘Donoghue, B, Owens, E, Renwick, L, Madigan, K, Kinsella, Aet al.Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophr Res 2012;135:128133.CrossRefGoogle ScholarPubMed
MacBeth, A, Gumley, APremorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal. Acta Psychiatr Scand 2008;117:8599.CrossRefGoogle ScholarPubMed
Maki, PH, Miettunen, J, Kaakinen, M, Moilanen, I, Taanila, A, Jones, PBet al.Negative symptoms precede the onset of first episode psychosis in a prospective general population sample of adolescents. European Psychiatry 2008 23 [Abstracts for Poster Session I].Google Scholar
Malla, AK, Norman, RM, Williamson, P, Cortese, L, Diaz, FThree syndrome concept of schizophrenia. A factor analytic study. Schizophr Res 1993;10:143150.CrossRefGoogle ScholarPubMed
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, TAssociation between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005;62:975983.CrossRefGoogle ScholarPubMed
Mason, O, Startup, M, Halpin, S, Schall, U, Conrad, A, Carr, VRisk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophr Res 2004;71:227237.CrossRefGoogle ScholarPubMed
McGorry, PD, Bell, RC, Dudgeon, PL, Jackson, HJThe dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 1998;28:935947.CrossRefGoogle ScholarPubMed
Miller, TJ, Zipursky, RB, Perkins, D, Addington, J, Woods, SW, Hawkins, KAet al.The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the prodromal sample. Schizophr Res 2003;61:1930.CrossRefGoogle ScholarPubMed
Murphy, BP, Stuart, AH, McGorry, PDDuration of untreated negative symptoms and duration of active negative symptoms: proof of concepts. Early Interv Psychiatry 2008;2:2733.CrossRefGoogle ScholarPubMed
Nieman, DH, Velthorst, E, Becker, HE, de Haan, L, Dingemans, PM, Linszen, DHet al.The Strauss and Carpenter prognostic scale in subjects clinically at high risk of psychosis. Acta Psychiatr Scand 2013;127:5361.CrossRefGoogle ScholarPubMed
Norman, RM, Scholten, DJ, Malla, AK, Ballageer, TEarly signs in schizophrenia spectrum disorders. J Nerv Ment Dis 2005;193:1723.CrossRefGoogle ScholarPubMed
Park, SG, Llerena, K, McCarthy, JM, Couture, SM, Bennett, ME, Blanchard, JJScreening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms. Schizophr Res 2012;135:139143.CrossRefGoogle ScholarPubMed
Peralta, V, Cuesta, MJ, de Leon, JPremorbid personality and positive and negative symptoms in schizophrenia. Acta Psychiatr Scand 1991;84:336339.CrossRefGoogle Scholar
Piskulic, D, Addington, J, Cadenhead, KS, Cannon, TD, Cornblatt, BA, Heinssen, Ret al.Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 2012;196:220224.CrossRefGoogle ScholarPubMed
Rabinowitz, J, Levine, SZ, Garibaldi, G, Bugarski-Kirola, D, Berardo, CG, Kapur, SNegative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res 2012;137:147150.CrossRefGoogle ScholarPubMed
Sayers, SL, Curran, PJ, Mueser, KTFactor structure and construct validity of the scale for the assessment of negative symptoms. Psychol Assess 1996;8:269280.CrossRefGoogle Scholar
Stahl, SM, Buckley, PFNegative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr Scand 2007;115:411.CrossRefGoogle Scholar
Strauss, GP, Gold, JMA new perspective on anhedonia in schizophrenia. Am J Psychiatry 2012;169:364373.CrossRefGoogle Scholar
Velthorst, E, Nieman, DH, Becker, HE, van de Fliert, R, Dingemans, PM, Klaassen, Ret al.Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 2009;109:6065.CrossRefGoogle ScholarPubMed
White, C, Stirling, J, Hopkins, R, Morris, J, Montague, L, Tantam, Det al.Predictors of 10-year outcome of first-episode psychosis. Psychol Med 2009;39:14471456.CrossRefGoogle ScholarPubMed
Yung, AR, McGorry, PDThe prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353370.CrossRefGoogle ScholarPubMed
Yung, AR, Phillips, LJ, Yuen, HP, McGorry, PDRisk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004;67:131142.CrossRefGoogle Scholar
Yung, AR, Yuen, HP, Berger, G, Francey, S, Hung, TC, Nelson, Bet al.Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk. Schizophr Bull 2007;33:673681.CrossRefGoogle ScholarPubMed
Zimmermann, R, Gschwandtner, U, Wilhelm, FH, Pflueger, MO, Riecher-Rossler, A, Fuhr, PEEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis. Schizophr Res 2010;123:208216.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.
14
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *